{"altmetric_id":238195,"counts":{"readers":{"mendeley":30,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["endometabpub"],"posts_count":1}},"selected_quotes":["J. Diab. Complic.: Psychological and quality of life changes in patients using GLP-1 analogues #diabetes #GLP-1"],"citation":{"abstract":"Using psychological and quality of life assessment tools, we prospectively studied changes in health-related quality of life and emotional well-being in patients who had commenced GLP-1 analogue therapy (exenatide) and compared them with new insulin starters.","abstract_source":"pubmed","altmetric_jid":"4f6fa4f03cf058f610002d53","doi":"10.1016\/j.jdiacomp.2011.03.002","first_seen_on":"2011-08-17T12:04:08+00:00","issns":["10568727"],"journal":"Journal of Diabetes & its Complications","last_mentioned_on":1313576902,"links":["http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1056872711000377"],"pmid":"21601480","pubdate":"2011-05-20T00:00:00+00:00","publisher":"Elsevier Inc.","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["endocrinology"],"title":"Psychological and quality of life changes in patients using GLP-1 analogues,","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/psychological-quality-life-changes-patients-using-glp1-analogues-5"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4508612,"mean":5.1916753366762,"rank":3038371,"this_scored_higher_than_pct":20,"this_scored_higher_than":905998,"rank_type":"exact","sample_size":4508612,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":60751,"mean":5.0583194403292,"rank":39925,"this_scored_higher_than_pct":15,"this_scored_higher_than":9276,"rank_type":"exact","sample_size":60751,"percentile":15},"this_journal":{"total_number_of_other_articles":263,"mean":2.2552213740458,"rank":153,"this_scored_higher_than_pct":23,"this_scored_higher_than":62,"rank_type":"exact","sample_size":263,"percentile":23},"similar_age_this_journal_3m":{"total_number_of_other_articles":2,"mean":1.25,"rank":2,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":2,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":2,"Librarian":1,"Researcher":4,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":6,"Student  > Postgraduate":1,"Student  > Master":5,"Other":3,"Student  > Bachelor":4,"Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":15,"Neuroscience":1,"Social Sciences":1,"Psychology":2,"Agricultural and Biological Sciences":7,"Unspecified":3,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"GB":1},"mendeley":{"DK":2}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/EndoMetabPub\/status\/103775165774700544","citation_ids":[238195],"posted_on":"2011-08-17T10:28:22+00:00","author":{"name":"Andrew Miller","url":"http:\/\/www.elsevier.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/831879691837571075\/BJOOZUB7_normal.jpg","description":"Senior Strategy Manager for #Elsevier #STM #journals. Leading the way in advancing science, technology & health. Opinions my own.","id_on_source":"endometabpub","tweeter_id":"337719507","geo":{"lt":51.75222,"ln":-1.25596,"country":"GB"},"followers":2146},"tweet_id":"103775165774700544"}]}}